Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. （打开新窗口）

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

来源‎: N Engl J Med 1998;338(8):499-505.

检索‎: PubMed 9468466

DOI码‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 （打开新窗口）

Childhood cancer and the Jehovah's Witness faith. （打开新窗口）

Frankel LS, Damme CJ, Eys JV.

来源‎: Pediatrics 1977;60(6):916-21.

检索‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 （打开新窗口）

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. （打开新窗口）

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

来源‎: J Clin Oncol 2004;22(24):4888-92.

检索‎: PubMed 15611504

DOI码‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 （打开新窗口）

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. （打开新窗口）

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

来源‎: JAMA Oncol 2022;8(1):79-87. 

检索‎: PubMed 34762093

DOI码‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ （打开新窗口）

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. （打开新窗口）

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

来源‎: Hematol Oncol 2014;32(1):40-6.

检索‎: PubMed 23963734

DOI码‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 （打开新窗口）

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. （打开新窗口）

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

来源‎: Haematologica 2000;85(11):1221-2.

检索‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 （打开新窗口）

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. （打开新窗口）

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

来源‎: Bone Marrow Transplant 2016;51(7):1002-3.

检索‎: PubMed 26950381

DOI码‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 （打开新窗口）

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. （打开新窗口）

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

来源‎: Bone Marrow Transplant 2003;32(4):433-6.

检索‎: PubMed 12900781

DOI码‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 （打开新窗口）

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. （打开新窗口）

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

来源‎: Bone Marrow Transplant 2005;36(8):715-20.

检索‎: PubMed 16113672

DOI码‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 （打开新窗口）

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. （打开新窗口）

Zwaan CM, Kaspers GJ

来源‎: Br J Haematol 2004;127(3):264-79.

检索‎: PubMed 15491285

DOI码‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 （打开新窗口）

Tratamiento de la leucemia aguda linfoblástica con poliquimioterapia sin hemoderivados en niños Testigos de Jehová​. [Treatment of acute lymphoblastic leukemia using combination chemotherapy without blood-derived products in Jehovah's Witness children. （打开新窗口）

​Tenorio-Guajardo G, Ferrer-Argote VE, Glender-Díaz W, Collazo-Jaloma J

来源‎: Rev Med Hosp Gen Mex 2009;72(1):16-9.

检索‎: ISSN 0185-1063

https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21009 （打开新窗口）